Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells - PubMed (original) (raw)
doi: 10.1038/ni1375. Epub 2006 Aug 13.
Affiliations
- PMID: 16906167
- DOI: 10.1038/ni1375
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
Marcel Batten et al. Nat Immunol. 2006 Sep.
Abstract
Interleukin 27 (IL-27) was first characterized as a proinflammatory cytokine with T helper type 1-inducing activity. However, subsequent work has demonstrated that mice deficient in IL-27 receptor (IL-27R alpha) show exacerbated inflammatory responses to a variety of challenges, suggesting that IL-27 has important immunoregulatory functions in vivo. Here we demonstrate that IL-27R alpha-deficient mice were hypersusceptible to experimental autoimmune encephalomyelitis and generated more IL-17-producing T helper cells. IL-27 acted directly on effector T cells to suppress the development of IL-17-producing T helper cells mediated by IL-6 and transforming growth factor-beta. This suppressive activity was dependent on the transcription factor STAT1 and was independent of interferon-gamma. Finally, IL-27 suppressed IL-6-mediated T cell proliferation. These data provide a mechanistic explanation for the IL-27-mediated immune suppression noted in several in vivo models of inflammation.
Comment in
- All in the family: IL-27 suppression of T(H)-17 cells.
Colgan J, Rothman P. Colgan J, et al. Nat Immunol. 2006 Sep;7(9):899-901. doi: 10.1038/ni0906-899. Nat Immunol. 2006. PMID: 16924249 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous